K. Chu

Neoadjuvant gemcitabine, docetaxel, and capecitabine followed by gemcitabine and capecitabine/radiation therapy and surgery in locally advanced, unresectable pancreatic adenocarcinoma

E. Hecht, J. Chabot, R. Fine, 2015, Cancer.

Prospective phase II trial of GTX in metastatic pancreatic cancer: Laboratory and clinical studies.

J. Chabot, R. Fine, J. Allendorf, 2013 .

Predictors of Response and Survival in Locally Advanced Adenocarcinoma of the Pancreas Following Neoadjuvant GTX with or Without Radiation Therapy

E. Hecht, W. Sherman, D. Leung, 2017, The oncologist.

Effect of Subtype of K-Ras Mutation on Survival in Resected Pancreatic Adenocarcinoma

W. Sherman, K. Chu, 2015 .

Phase II trial of GTX chemotherapy in metastatic pancreatic cancer.

J. Chabot, R. Fine, M. Maurer, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.